A recent report indicated that once-daily administration of miglitol at breakfast increased the AUC of active plasma GLP-1 levels even after lunch in sitagliptin-treated patients with type 2 diabetes [33]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.